Amanta Healthcare’s Rs 126 crore IPO was subscribed 23.04 times, driven by NIIs and RIIs. Trading at an 8% GMP, the stock may list around Rs 136. The company’s sterile liquid pharmaceuticals focus and global certifications position it for strong growth.
Originally published by The Economic Times https://economictimes.indiatimes.com/markets